By Michael Dabaie

Eli Lilly and Company (LLY) and Evidation Health expanded their collaboration with a multi-year agreement to provide Lilly with global access to Evidation's Andromeda data platform.

Lilly scientists and researchers will have access to Evidation's data platform to uncover new ways to measure patients' health by accessing consented data derived from smartphones, connected sensors and wearables.

Lilly didn't disclose the terms of the agreement.

With Andromeda, Lilly scientists can use Evidation-built algorithms to process raw data for use in clinical studies or to create their own predictive models, the company said.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

December 14, 2018 07:33 ET (12:33 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Eli Lilly Charts.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Eli Lilly Charts.